Literature DB >> 735044

Herpes zoster.

J B Reuler.   

Abstract

Herpes zoster is a disorder frequently encountered in adults. The natural history is often poorly appreciated and management is frustrating. Recent studies have critically evaluated newer therapeutic modalities. The epidemiology, clinical manifestations, complications and therapeutic alternatives of herpes zoster deserve review.

Mesh：

Year:  1978        PMID： 735044      PMCID： PMC1238433     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


  31 in total

1.  Bladder dysfunction secondary to herpes zoster.

Authors:  M W Kent; W G Guerriero
Journal:  South Med J       Date:  1975-08       Impact factor: 0.954

2.  Should patients with zoster receive zoster immune globulin?

Authors:  S A Uduman; A A Gershon; P A Brunell
Journal:  JAMA       Date:  1975-12-08       Impact factor: 56.272

Review 3.  Varicella-zoster ophthalmicus.

Authors:  D Pavan-Langston
Journal:  Int Ophthalmol Clin       Date:  1975

Review 4.  Herpes zoster oticus and facial paralysis.

Authors:  J A Crabtree
Journal:  Otolaryngol Clin North Am       Date:  1974-06       Impact factor: 3.346

Review 5.  Passive immunization against varicella-zoster infections and other modes of therapy.

Authors:  P A Brunell; A A Gershon
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

6.  Zoster immune globulin. A further assessment.

Authors:  A A Gershon; S Steinberg; P A Brunell
Journal:  N Engl J Med       Date:  1974-01-31       Impact factor: 91.245

7.  Letter: Idoxuridine in herpes zoster.

Authors:  J R Simpson
Journal:  Br Med J       Date:  1974-08-24

8.  The effects of early corticosteroid therapy on the skin eruption and pain of herpes zoster.

Authors:  W H Eaglstein; R Katz; J A Brown
Journal:  JAMA       Date:  1970-03-09       Impact factor: 56.272

9.  Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study.

Authors:  R J Whitley; L T Ch'ien; R Dolin; G J Galasso; C A Alford
Journal:  N Engl J Med       Date:  1976-05-27       Impact factor: 91.245

10.  Idoxuridine in herpes zoster: further evaluation of intermittent topical therapy.

Authors:  R Dawber
Journal:  Br Med J       Date:  1974-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.